Companies: 10,795·Total market cap: $144.5T
Aethlon Medical, Inc.

Aethlon Medical, Inc.

AEMDNASDAQHealthcare● Active
$2.03
+$0.12(+6.28%)
Market Cap$1545400
P/E Ratio
52W High$29.6
52W Low$1.36

Aethlon Medical, Inc.(AEMD)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

aemd · 股价预测 · 3 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 3 位华尔街分析师

SellBuy

Hold

3 位分析师

共识

评级分布

Strong Buy
0
Buy
1
Hold
2
Sell
0
Strong Sell
0
合计: 3 · 买入占比: 33.3%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $2.03

Aethlon Medical, Inc.(AEMD)的分析师共识为 Hold,基于过去 3 个月内 3 位华尔街分析师的评级。AEMD 的 12 个月平均目标价为 $0.00,相对当前价 $2.03 代表 +0.0% 的潜在上行空间。

短期股价预测

📅
财报窗口期

在 ±3 天财报窗口期内暂停短期预测,以避免不可靠信号。

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Elevated Volatility — Earnings Window Active (±3 days)· Technical signals still shown. M3 predictions paused.

Market Sentiment

BEARISH

Based on 14 technical indicators

0%21%79%
0Buy
3Neutral
11Sell
RSI (14)49.8Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · AEMD · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$2.08SELL
MA 10$2.35SELL
MA 20$2.23SELL
MA 50$2.24SELL
MA 100$2.23SELL
MA 200$0.00NEUTRAL
Current $AEMD · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$2.10SELL
EMA 10$2.19SELL
EMA 20$2.23SELL
EMA 50$2.26SELL
EMA 100$2.63SELL
EMA 200$0.00NEUTRAL
Current $AEMD · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2025-08-14
Maintains
NeutralNeutral
HC Wainwright & Co.2025-03-10
Maintains
BuyBuy
HC Wainwright & Co.2025-02-19
Maintains
BuyBuy
HC Wainwright & Co.2025-01-30
Maintains
BuyBuy
HC Wainwright & Co.2024-11-15
Maintains
BuyBuy
HC Wainwright & Co.2024-06-24
Maintains
BuyBuy
HC Wainwright & Co.2024-03-04
Maintains
BuyBuy
HC Wainwright & Co.2023-10-24
Maintains
BuyBuy
Maxim Group2022-11-15
Downgrade ↓
BuyHold
Maxim Group2022-11-14
Downgrade ↓
BuyHold

Wall Street analysts have recently issued updated ratings on Aethlon Medical, Inc. (AEMD) stock. Of the recent 17 rating actions, 0 were upgrades and 2 were downgrades. 3 analysts currently cover AEMD.

分析师推荐趋势

Buy ratings101
Hold ratings01↑ +1
Sell ratings00

AEMD analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$126M

Revenue Next Year

$0M

↓ 100.0% YoY

EPS This Year

$-10.21

EPS Next Year

$-2.21

↓ 78.4% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast AEMD EPS of $-10.21 for the current fiscal year, based on estimates from 1 analysts. The AEMD revenue forecast is $126M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

AEMD 股价预测由两类独立数据源支撑:来自 3 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。AEMD 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Hold。

Aethlon Medical, Inc. 在 NASDAQ 上市,代码 AEMD。AEMD 在 2027 年的整体展望偏中性/分化,在覆盖分析师中约 33% 对应 Hold 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

AEMD 预测 · 8 个问题

根据 3 位华尔街分析师,AEMD 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $2.03,隐含约 +0.0% 的上行空间。

AEMD 目标价AEMD 分析师目标价AEMD 12个月目标价目标价 AEMD

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.